Cytotoxic T-Cells in Peripheral Blood in Women with
                    Endometriosis

N. Slabe; H. Meden-Vrtovec; I. Verdenik; R. Kosir-Pogacnik; A. Ihan

doi:10.1055/s-0033-1350702

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2013; 73(10): 1042-1048
DOI: 10.1055/s-0033-1350702

Original Article

GebFra Science

Georg Thieme Verlag KG Stuttgart · New York

Cytotoxic T-Cells in Peripheral Blood in Women with Endometriosis

Zytotoxische T-Zellen im peripheren Blut bei Frauen mit Endometriose

N. Slabe

¹Obstetrics and Gynecology, University Clinical Centre Ljubljana, Ljubljana, Slovenia

,

H. Meden-Vrtovec

¹Obstetrics and Gynecology, University Clinical Centre Ljubljana, Ljubljana, Slovenia

,

I. Verdenik

¹Obstetrics and Gynecology, University Clinical Centre Ljubljana, Ljubljana, Slovenia

,

R. Kosir-Pogacnik

¹Obstetrics and Gynecology, University Clinical Centre Ljubljana, Ljubljana, Slovenia

,

A. Ihan

²Institute of Microbiology and Immunology, Faculty of Medicine, Ljubljana, Slovenia

› Author Affiliations

Abstract

Aim: The etiology of endometriosis remains unknown, but increasing evidence suggests that immune regulation may be important. Our study aimed to evaluate peripheral blood lymphocyte subpopulations during the menstrual cycle in women with peritoneal and ovarian endometriosis relative to healthy women. Methods: In this study, 65 women with endometriosis (37 in the follicular phase and 28 in the luteal phase of the menstrual cycle) and 61 healthy women (33 in the follicular phase and 28 in the luteal phase) were enrolled. Flow cytometric analysis measured peripheral blood lymphocyte subpopulations. The serum levels of cortisol were also determined. Results: In healthy controls, we detected an increased concentration of cytotoxic (CD8⁺) T cells and activated (HLA-DR) T cells in the luteal phase compared with the follicular phase of the menstrual cycle (p = 0.020 and p = 0.045), whereas no such fluctuation was detected in endometriosis. However, a marked increase in regulatory T-cell concentration in the luteal phase was detected only in endometriosis patients (p = 0.005). Women with endometriosis had higher levels of serum cortisol (p = 0.022), which correlated with the concentration of regulatory T cells (p = 0.048). Conclusions: Women with endometriosis do not exhibit fluctuations in the concentrations of cytotoxic and activated peripheral blood lymphocytes during the menstrual cycle. The marked fluctuation of regulatory T cells detected in endometriosis could be attributed to altered immune response.

Zusammenfassung

Einleitung: Endometriose ist ein häufiges, jedoch komplexes gynäkologisches Syndrom unbekannter Pathogenese, von dem Frauen im gebärfähigen Alter befallen sind. Die Ätiologie der Endometriose bleibt unbekannt, aber immer häufigere Beweise zeigen, dass das Immunsystem dabei eine große Rolle spielt. Unsere Studie zielte darauf ab, die peripheren Blutlymphozytensubpopulationen während des Menstruationszyklus bei Frauen mit Peritoneal- und Ovarialendometriose im Vergleich zu gesunden Frauen zu bewerten. Methoden: Die Studie umfasste 65 Frauen mit Endometriose (37 in der Follikelphase und 28 in der Lutealphase des Menstruationszyklus) und 61 gesunde Frauen (33 in der Follikelphase und 28 in der Lutealphase des Menstruationszyklus). Die Lymphozytensubpopulationen wurden mittels Durchflusszytometrie festgestellt. Der Serumspiegel von Cortisol wurde ebenfalls bestimmt. Ergebnisse: Bei gesunden Probanden fanden wir im peripheren Blut eine erhöhte Konzentration von zytotoxischen (CD8⁺) T-Zellen und aktivierten (HLA-DR) T-Zellen in der Lutealphase gegenüber der Follikelphase des Menstruationszyklus (p = 0,020 und p = 0,045), während keine solche Schwankung in der Endometriose festgestellt wurde. Ein deutlicher Anstieg der regulatorischen T-Zellen-Konzentration in der Lutealphase wurde nur bei Frauen mit Endometriose ermittelt. Frauen mit Endometriose hatten einen höheren Serumspiegel von Cortisol (p = 0,022), der mit der Konzentration von regulatorischen T-Zellen (p = 0,048) korreliert. Schlussfolgerung: Frauen mit Endometriose zeigen keine Konzentrationsschwankungen von zytotoxischen und aktivierten Lymphozyten im peripheren Blut während des Menstruationszyklus. In der Endometriose nachgewiesene Schwankungen von regulatorischen T-Zellen können auf veränderte Immunantwort zurückgeführt werden.

Key words

endometriosis - gynecology - infertility - regulatory T cells - cell immunity

Schlüsselwörter

Endometriose - Gynäkologie - Infertilität - regulatorische T-Zellen - Zell-Immunität

Full Text

References

References
1 Bulun SA. Endometriosis. New Engl J 2009; 360: 268-279
2 Pearce CL, Templeman C, Rossing MA et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13: 385-394
3 Baldi A, Campioni M, Signorile PG. Endometriosis; pathogenesis, diagnosis, therapy association with cancer (Review). Oncol Rep 2008; 19: 843-846
4 Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001; 75: 1-10
5 Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001; 76: 223-231
6 Oosterlynck DJ, Cornillie FJ, Waer M et al. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991; 56: 45-51
7 Lawson C, Al-Akoum M, Maheux R et al. Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions. Reproduction 2007; 133: 265-274
8 Flores I, Rivera E, Ruiz LA et al. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril 2007; 87: 1180-1199
9 Burney RO, Talbi S, Hamilton AE et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007; 148: 3814-3826
10 Burghaus S, Klingsiek P, Fasching PA et al. Risk factors for endometriosis in a German case-control study. Geburtsh Frauenheilk 2011; 71: 1073-1079
11 Arruvito L, Sanz M, Banham AH et al. Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178: 2572-2578
12 Giatromanolaki A, Bates GJ, Koukourakis MI et al. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol 2008; 110: 216-221
13 Nandakumar S, Miller WT, Kumaraguru U. T regulatory cells: an overview and intervention techniques to modulate allergy outcome. Clin Mol Allergy 2009; 7: 5
14 Thornton AM. T regulatory cells. Curr Biol 2005; 15: 582
15 Sakaguchi S, Yamaguchi T, Nomura T et al. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787
16 Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 2004; 114: 1209-1217
17 Basta P, Majka M, Jozwicki W et al. The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 2010; 8: 116
18 Berbic M, Hey-Cunningham AJ, Ng C et al. The role of Foxp3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod 2010; 25: 900-907
19 Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011; 88: 149-155
20 Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4+CD25+ regulatory T cells by promoting their proliferation. Immunology 2006; 118: 58-65
21 Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometric 1980; 36: 343-346
22 Halis G, Mechsner S, Ebert AD. The diagnosis and treatment of deep infiltrating endometriosis. Dtsch Arztebl Int 2010; 107: 446-456
23 Ribič-Pucelj M. Endometrioza-epidemiologija, etiologija, patofiziologija in klasifikacija. In: Ribič-Pucelj M, eds. Endoskopske operacije v ginekologiji. 1st ed. Radovljica: Didakta; 2007: 163-167
24 Dejaco C, Duftner C, Schirmer M. Are regulatory T-cells linked with aging?. Exp Gerontol 2006; 41: 339-345
25 Haynes L, Maue AC. Effects of aging on T cell function. Curr Opin Immunol 2009; 21: 414-417
26 Wang L, Xie Y, Zhu LJ et al. An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: a systematic review. Biomed Environ Sci 2010; 23: 327-332
27 Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers in game. J Immunol 2011; 187: 2061-2066
28 Pukhalʼskiĭ AL, Shmarina GV, Aleshkin VA. Regulatory T-cells: modern approaches to optimization of their numbers. Vestn Ross Akad Med Nauk 2011; 8: 24-33
29 Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998; 4: 741-751
30 Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol 2003; 55: 333-345
31 Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E et al. Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 2011; 118: 6-16
32 Rusdi G, Sumapraja K, Hadisaputra W. Distribution of regulatory T-cell (Cd4+, Cd25+) in the peritoneal fluid of endometriosis patients. Ind J Obst Gynecol 2010; 34: 19-23
33 Olkowska-Truchanowicz J, Bocian K, Maksym RB et al. CD4⁺ CD25⁺ FOXP3⁺ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod 2013; 28: 119-124
34 Podgaec S, Rizzo LV, Fernandes LF et al. CD4(+) CD25(high) Foxp3(+) cells increased in the peritoneal fluid of patients with endometriosis. Am J Reprod Immunol 2012; 68: 301-308
35 Lee S, Kim J, Jang B et al. Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women. J Immunol 2010; 185: 756-762
36 Viganò P, Vercellini P, Di Blasio AM et al. Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis. Fertil Steril 1991; 56: 894-899
37 Budiu RA, Diaconu I, Chrissluis R et al. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Dis Model Mech 2009; 2: 593-603
38 Lima AP, Moura MD, Rosa e Silva AA. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res 2006; 39: 1121-1127
39 Chrousos GP, Elenkov IJ. Interactions of the endocrine and immune Systems. In: DeGroot LJ, Jameson JL, eds. Endocrinology. New York: Academic Press; 2000: 571-586
40 The adrenal Glands. In: Berne RM, Levy MN, Koeppen BM, Staton BA, eds. Physiology. Missouri: Mosby; 2004: 883-919
41 Pfeifer M. Bolezni endokrinih žlez. In: Kocijančič A, Mrevlje F, Štajer D, eds. Interna Medicina. Ljubljana: Littera picta; 2005: 793-896
42 Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001; 76: 223-231
43 Sinaii N, Cleary SD, Ballweg ML et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17: 2715-2724
44 Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis?. Autoimmun Rev 2012; 11: 806-814
45 Matarese G, De Placido G, Nikas Y et al. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003; 9: 223-228
46 Petta CA, Arruda MS, Zantut-Wittmann DE et al. Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod 2007; 22: 2693-2697
47 Matorras R, Ocerin I, Unamuno M et al. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjögrenʼs syndrome. Lupus 2007; 16: 736-740